DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 8, 2005, Pages 3404-3413

  Cui, Longzhu ^a   Lian, Jian Qi ^a,b   Neoh, Hui Min ^a   Reyes, Ethel ^a   Hiramatsu, Keiichi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; GLYCOPEPTIDE; GREEN FLUORESCENT PROTEIN; IMIPENEM; OXACILLIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIUM MUTANT; BIOSYNTHESIS; CELL STRUCTURE; CONTROLLED STUDY; DNA MICROARRAY; FUSION GENE; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC COMPLEMENTATION; GENETIC TRANSCRIPTION; GRAF GENE; HUMAN; KNOCKOUT GENE; MGRA GENE; MINIMUM INHIBITORY CONCENTRATION; MSRA2 GENE; NONHUMAN; NORTHERN BLOTTING; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; GENE EXPRESSION PROFILING; HUMANS; MICROBIAL SENSITIVITY TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 23044474892     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.8.3404-3413.2005     Document Type: Article

References (56)

1. B activity in Staphylococcus aureus. Antimicrob. Agents Chemother. 45:1714-1720.
2. Bischoff, M., M. Roos, J. Putnik, A. Wada, P. Glanzmann, P. Giachino, P. Vaudaux, and B. Berger-Bachi. 2001. Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance. FEMS Microbiol. Lett. 194:77-82.
3. +-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide- resistant isolate. J. Bacteriol. 179:6756-6763.
4. Boyle-Vavra, S., H. Labischinski, C. C. Ebert, K. Ehlert, and R. S. Daum. 2001. A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 45:280-287.
5. Cui, L., and K. Hiramatsu. 2003. Vancomycin-resistant Staphylococcus aureus, p. 187-212. In A. C. Fluit and F. J. Schmitz (ed.), MRSA: current perspectives. Caister Academic Press, Norfolk, England.
6. Cui, L., X. Ma, K. Sato, K. Okuma, F. C. Tenover, E. M. Mamizuka, C. G. Gemmell, M.-N. Kim, M.-C. Ploy, N. El Solh, V. Ferraz, and K. Hiramatsu. 2003. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41:5-14.
7. Cui, L., H. Murakami, K. Kuwahara-Arai, H. Hanaki, and K. Hiramatsu. 2000. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus MuSO. Antimicrob. Agents Chemother. 44:2276-2285.
8. Egeter, O., and R. Bruckner. 1995. Characterization of a genetic locus essential for maltose-maltotriose utilization in Staphylococcus xylosus. J. Bacteriol. 177:2408-2415.
9. Finan, J. E., G. L. Archer, M. J. Pucci, and M. W. Climo. 2001. Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:3070-3075.
10. Gemmell, C. G. 2004. Glycopeptide resistance in Staphylococcus aureus: is it a real threat? J. Infect. Chemother. 10:69-75.
11. Hanaki, H., K. Kuwahara-Arai, S. Boyle-Vavra, R. S. Daum, H. Labischinski, and K. Hiramatsu. 1998. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J. Antimicrob. Chemother. 42:199-209.
12. Hanaki, H., H. Labischinski, Y. Inaba, N. Kondo, H. Murakami, and K. Hiramatsu. 1998. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. J. Antimicrob. Chemother. 42:315-320.
13. Hill, A., E. Brown, M. Whitley, G. Tucker-Kellogg, C. Hunter, and D. Slonim. 21 November 2001, posting date. Evaluation of normalization procedures for oligonucleotide array data based on spiked cRNA controls. Genome Biol. 2:RESEARCH0055.1-0055.13. [Online.] doi:10.1186/gb-2001-2-12-research0055.
14. 2 fixation and microaerobiosis. J. Bacteriol. 172:2071-2078.
15. Hiramatsu, K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1:147-155.
16. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
17. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136. (Letter.)
18. Hiramatsu, K., T. Ito, and H. Hanaki. 1999. Mechanisms of methicillin and vancomycin resistance in Staphylococcus aureus, p. 211-242. In R. G. Finch and R. J. Williams (ed.), Bailliere's clinical infectious diseases, vol. 5. Bailliere Tindall, London, United Kingdom.
19. Ingavale, S. S., W. Van Wamel, and A. L. Cheung. 2003. Characterization of RAT, an autolysis regulator in Staphylococcus aureus. Mol. Microbiol. 48: 1451-1466.
20. Jensen, L., S. Ladefoged, S. Birkelund, and G. Christiansen. 1995. Selection of Mycoplasma hominis PG21 deletion mutants by cultivation in the presence of monoclonal antibody 552. Infect. Immun. 63:3336-3347.
21. Kim, M.-N., C. H. Pai, J. H. Woo, J. S. Ryu, and K. Hiramatsu. 2000. Vancomycin-intermediate Staphylococcus aureus in Korea. J. Clin. Microbiol. 38:3879-3881.
22. Komatsuzawa, H., T. Fujiwara, H. Nishi, S. Yamada, M. Ohara, N. McCallum, B. Berger-Bachi, and M. Sugai. 2004. The gate controlling cell wall synthesis in Staphylococcus aureus. Mol. Microbiol. 53:1221-1231.
23. Komatsuzawa, H., K. Ohta, S. Yamada, K. Ehlert, H. Labischinski, J. Kajimura, T. Fujiwara, and M. Sugai. 2002. Increased glycan chain length distribution and decreased susceptibility to moenomycin in a vancomycin-resistant Staphylococcus aureus mutant. Antimicrob. Agents Chemother. 46: 75-81.
24. Kondo, N., K. Kuwahara-Arai, H. Kuroda-Murakami, E. Tateda-Suzuki, and K. Hiramatsu. 2001. Eagle-type methicillin resistance: new phenotype of high methicillin resistance under mec regulator gene control. Antimicrob. Agents Chemother. 45:815-824.
25. Kuroda, M., H. Kuroda, T. Oshima, F. Takeuchi, H. Mon, and K. Hiramatsu. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49:807-821.
26. Kuroda, M., K. Kuwahara-Arai, and K. Hiramatsu. 2000. Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and MuSO by cDNA differential hybridization method. Biochem. Biophys. Res. Commun. 269:485-490.
27. Kuroda, M., T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, Y. Nagai, J. Lian, T. Ito, M. Kanamori, H. Matsumani, A. Maruyama, H. Murakami, A. Hosoyama, Y. Mizutani-Ui, N. K. Takahashi, T. Sawano, R. Inoue, C. Kaito, K. Sekimizu, H. Hirakawa, S. Kuhara, S. Goto, J. Yabuzaki, M. Kanehisa, A. Yamashita, K. Oshima, K. Kuruya, C. Yoshino, T. Shiba, M. Hattori, N. Ogasawara, H. Hayashi, and K. Hiramatsu. 2001. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
28. Kuwahara-Arai, K., N. Kondo, S. Hori, E. Tateda-Suzuki, and K. Hiramatsu. 1996. Suppression of methicillin resistance in a metyl-containing pre-methicillin-resistant Staphylococcus aureus strain is caused by the mecl-mediated repression of PBP 2′ production. Antimicrob. Agents Chemother. 40:2680-2685.
29. Lin, J., B. Goldman, and V. Stewart. 1994. The nasFEDCBA operon for nitrate and nitrite assimilation in Klebsiella pneumoniae M5al. J. Bacteriol. 176:2551-2559.
30. Linares, J. 2001. The VISA/GISA problem: therapeutic implications. Clin. Microbiol. Infect. 7(Suppl. 4):8-15.
31. Luong, T. T., S. W. Newell, and C. Y. Lee. 2003. Mgr, a novel global regulator in Staphylococcus aureus. J. Bacteriol. 185:3703-3710.
32. Macinga, D. R., M. Parojcic, and P. N. Rather. 1995. Identification and analysis of aarP, a transcriptional activator of the 2′-N- acetyltransferase in Providencia stuartii. J. Bacteriol. 177:3407-3413.
33. Maki, H., N. McCallum, M. Bischoff, A. Wada, and B. Berger-Bächi. 2004. tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 48:1953-1959.
34. +-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:166-172.
35. Mongodin, E., J. Finan, M. W. Climo, A. Rosato, S. Gill, and G. L. Archer. 2003. Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin. J. Bacteriol. 185:4638-4643.
36. Moore, M. R., F. Perdreau-Remington, and H. F. Chambers. 2003. Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob. Agents Chemother. 47:1262-1266.
37. Morikawa, K., A. Maruyama, Y. Inose, M. Higashide, H. Hayashi, and T. Ohta. 2001. Overexpression of sigma factor, varsigma (B), urges Staphylococcus aureus to thicken the cell wall and to resist beta-lactams. Biochem. Biophys. Res. Commun. 288:385-389.
38. Nilsson, B., L. Abrahmsen, and M. Uhlen. 1985. Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors. EMBO J. 4:1075-1080.
39. Ohki, R., Giyanto, K. Tateno, W. Masuyama, S. Moriya, K. Kobayashi, and N. Ogasawara. 2003. The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis. Mol. Microbiol. 49:1135-1144.
40. Ohta, T., H. Hirakawa, K. Morikawa, A. Maruyama, Y. Inose, A. Yamashita, K. Oshima, M. Kuroda, M. Hattori, K. Hiramatsu, S. Kuhara, and H. Hayashi. 2004. Nucleotide substitutions in Staphylococcus aureus strains, Mu50, Mu3, and N315. DNA Res. 11:51-56.
41. Oliveira, G. A., A. M. Aquila, R. A. Masiero, C. Levy, S. G. Gomes, L. Cui, K. Hiramatsu, and E. M. Mamizuka. 2001. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect. Control Hosp. Epidemiol. 22:443-448.
42. Pechous, R., N. Ledala, B. J. Wilkinson, and R. K. Jayaswal. 2004. Regulation of the expression of cell wall stress stimulon member gene msrA1 in methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 48:3057-3063.
43. Rossi, J., M. Bischoff, A. Wada, and B. Berger-Bächi. 2003. MsrR, a putative cell envelope-associated element involved in Staphylococcus aureus sarA attenuation. Antimicrob. Agents Chemother. 47:2558-2564.
44. Sakoulas, G., G. M. Eliopoulos, R. C. Moellering, Jr., C. Wennersten, L. Venkalaramaii, R. P. Novick, and H. S. Gold. 2002. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 46: 1492-1502.
45. Schaaff, F., A. Reipert, and G. Bierbaum. 2002. An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 46:3540-3548.
46. Shlaes, D. M., J. H. Shlaes, S. Vincent, L. Etter, P. D. Fey, and R. V. Goering. 1993. Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex. Antimicrob. Agents Chemother. 37:2432-2437.
47. Sieradzki, K., M. G. Pinho, and A. Tomasz. 1999. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J. Biol. Chem. 274:18942-18946.
48. Sieradzki, K., and A. Tomasz. 1999. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus. J. Bacteriol. 181:7566-7570.
49. Siewert, G., and J. Strominger. 1968. Biosynthesis of the peptidoglycan of bacterial cell walls. XI. Formation of the isoglutamine amide group in the cell walls of Staphylococcus aureus. J. Biol. Chem. 243:783-790.
50. Singh, V. K., J. L. Schmidt, R. K. Jayaswal, and B. J. Wilkinson. 2003. Impact of sigB mutation on Staphylococcus aureus oxacillin and vancomycin resistance varies with parental background and method of assessment. Int. J. Antimicrob. Agents 21:256-261.
51. Smith, L. T., J.-A. Pocard, T. Bernard, and D. Le Rudulier. 1988. Osmotic control of glycine betaine biosynthesis and degradation in Rhizobium meliloti. J. Bacteriol. 170:3142-3149.
52. Suzuki, E., K. Hiramatsu, and T. Yokota. 1992. Survey of methicillin-resistant clinical strains of coagulase-negative staphylococci for mecA gene distribution. Antimicrob. Agents Chemother. 36:429-434.
53. Truong-Bolduc, Q. C., X. Zhang, and D. C. Hooper. 2003. Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus. J. Bacteriol. 185:3127-3138.
54. Utaida, S., P. Dunman, D. Macapagal, E. Murphy, S. Projan, V. Singh, R. Jayaswal, and B. Wilkinson. 2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149:2719-2732.
55. Velasco, A., J. Leguina, and A. Lazcano. 2002. Molecular evolution of the lysine biosynthetic pathways. J Mol. Evol 55:445-459.
56. Wiltshire, M. D., and S. J. Foster. 2001. Identification and analysis of Staphylococcus aureus components expressed by a model system of growth in serum. Infect. Immun. 69:5198-5202.